Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderately to Severely Active Rheumatoid Arthritis

NCT06972446 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06972446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06972446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderately to Severely Active Rheumatoid Arthritis
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Recruiting
Start date
June 20, 2025
Completion date
November 30, 2027
Enrollment
180 (estimated)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis